MedPath

Participant Satisfaction With the BUILD Mobile Application

Not Applicable
Completed
Conditions
Satisfaction, Personal
Interventions
Device: DISC-CON
Device: DISC-MVP
Registration Number
NCT05948670
Lead Sponsor
Woebot Health
Brief Summary

This study explores user satisfaction with the BUILD mobile application.

Detailed Description

This exploratory randomized, double-blind, controlled trial explores user satisfaction with the BUILD mobile application. The BUILD app uses a relational agent (Woebot) to engage users in therapeutic conversations. Eligible participants will be randomized to one of two treatment conditions: (1) an experimental condition in which Woebot uses large language models to understand user sentiment, and based on this understanding of natural language generate responses through a controlled process or (2) a digital control condition in which Woebot selects from a list of responses based on natural language processing. Participants will receive instructions on downloading and using the BUILD app in order to access the intervention to which they were assigned. Participants will use the app as instructed and will complete assessments for the primary endpoint at Week 2 (EOT) with additional measures being collected at Baseline, Day 3, and Week 2. Results from this study will provide preliminary data on user satisfaction and feasibility and inform product development iteration for inclusion in a statistically powered clinical randomized controlled trial.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
175
Inclusion Criteria
  1. Must be 18+ years of age and older
  2. Must own or have regular access to a smartphone with a recent operating system installed (Android: OS 8.0 or higher, Apple: iOS 13.0 or higher) with reliable Wi-Fi access or sufficient data plan to engage with assigned treatment condition for the duration of the study
  3. Must be available and committed to engage with the program and complete assessments for a 2-week duration
  4. Must be able to read and write in English
  5. Must have primary residence in the United States
Exclusion Criteria
  1. Current suicidal ideation with a plan and/or intent or a suicide attempt within the past 12 months
  2. Previous Woebot use

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
DISC-CONDISC-CONParticipants randomized to the digital control condition, DISC-CON, will be asked to download and use the BUILD study application. They will have access to the app throughout the 2 week study.
DISC-MVPDISC-MVPParticipants randomized to the experimental condition, DISC-MVP, will be asked to download and use the BUILD study application. They will have access to the app throughout the 2 week study.
Primary Outcome Measures
NameTimeMethod
User Satisfaction as Measured by the Client Satisfaction Questionnaire (CSQ-8)Post-intervention at Week 2

The CSQ-8 is an 8-item measure used to assess client's satisfaction with treatment.Total scores range from 8-32, with high scores indicating greater satisfaction with the treatment.

Secondary Outcome Measures
NameTimeMethod
User Satisfaction Amongst a Sub-sample of Adults With at Least Mild Symptoms of Depression and/or Anxiety.Post-intervention at Week 2

The CSQ-8 is an 8-item measure used to assess client's satisfaction with treatment.Total scores range from 8-32, with high scores indicating greater satisfaction with the treatment.

Trial Locations

Locations (1)

Woebot Investigational Site

🇺🇸

San Francisco, California, United States

© Copyright 2025. All Rights Reserved by MedPath